Philips’ home ventilator recall is still in full force—spanning more than 18 months and over 5 million sleep apnea devices around the globe—and competitor ResMed has been looking to pick up the slack ...

As Philips reaches a consent decree agreement with the FDA that will temporarily suspend its sales of sleep therapy devices in the U.S., competitor ResMed, meanwhile, is ramping up its product ...